Kezar Life Sciences, Inc. , a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States.
Kezar Life Sciences stock last closed at $4.44, up 3.15% from the previous day, and has decreased 21.52% in one year. It has overperformed other stocks in the Biotechnology industry by 0.5 percentage points. Kezar Life Sciences stock is currently +22.65% from its 52-week low of $3.62, and -51.63% from its 52-week high of $9.18.
At the moment, there are 7.31M KZR shares outstanding. The market cap of KZR is $32.44M. In the past 24 hours, 46,600 KZR shares were traded.
You need an online brokerage account to access the NASDAQ market and buy KZR shares.
Based on our experience, eToro is the best brokerage. Here's why:
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected the right brokerage, you need to fill out some personal details so you can buy KZR stock today.
Now that you have finished signing up on one of the best stock trading apps, you can securely and quickly fund your account:
Check out the walkthrough below for more details depositing funds into your brokerage account.
After you have decided on the best place to buy Kezar Life Sciences stock, it's absolutely critical to research their stock prior to buying, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis.
You can view all of the due diligence checks on KZR's stock page.
Investors use many financial metrics, analyses, models, and charts to gauge KZR's intrinsic value.
Using relative valuations ratios:
You can do more valuation analysis on KZR's stock here.
You can dig deeper into what analysts are saying on the Kezar Life Sciences stock forecast page.
Last year, KZR revenue was $0.00. In the past 1 years, KZR's revenue has grown by -100% per year. This was slower than the Biotechnology industry average of 42.28%.
Dig into KZR's earnings and revenue performance here.
In the last 12 months, insiders at KZR have sold more shares than they have bought.
Learn more about who owns KZR stock here.
No, Kezar Life Sciences doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main options:
Hit the Open button and eToro will place the order.
If you need additional assistance investing in stocks on eToro, watch the helpful video below:
Now that you own some KZR stock, you'll want to stay up-to-date on your new company.
Start a watchlist to get the latest updates about your KZR stock.
To summarize, here are the 6 steps to buy stock in Kezar Life Sciences:
If you require a online brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep track of your investment in Kezar Life Sciences, create a watchlist on WallStreetZen today.